AAV Gene Therapy Vectors: Design and Production
·2 min read

AAV Gene Therapy Vectors: Design and Production

Design and produce AAV vectors for gene therapy. Learn capsid engineering, titer optimization, and tropism selection. Warnings about integration risks and immune responses.

By Dr. Lisa Chen, Gene Therapy EngineerAAV vectorsgene therapyviral vectors

AAV Gene Therapy Vectors

Adeno-Associated Virus (AAV) is the leading viral vector for gene therapy. Safe, effective, but with integration and immune response risks.

Vector Design

class AAVVector:
    """
    AAV vector components:
    - ITRs (Inverted Terminal Repeats): Required for packaging
    - Transgene: Your therapeutic gene
    - Promoter: Tissue-specific expression
    - Capsid: Determines which cells infected
    """

    def __init__(self, transgene, promoter, capsid_serotype):
        self.transgene = transgene  # e.g., "Factor IX" for hemophilia
        self.promoter = promoter    # e.g., "liver-specific"
        self.capsid = capsid_serotype  # AAV8 for liver, AAV9 for CNS

    def design_vector(self):
        """
        AAV genome (max 4.7 kb):
        ITR-Promoter-Transgene-PolyA-ITR

        ⚠️ Size limit: Must fit in 4.7kb including promoter + transgene
        """
        return f"ITR-{self.promoter}-{self.transgene}-PolyA-ITR"

Capsid Engineering

# Different serotypes target different tissues
CAPSID_TROPISM = {
    'AAV1': 'Muscle, heart',
    'AAV2': 'Liver, CNS, retina',
    'AAV5': 'CNS, lung',
    'AAV8': 'Liver (best for hepatic gene therapy)',
    'AAV9': 'CNS, heart (crosses blood-brain barrier)',
    'AAVrh10': 'Broad tropism',
}

def select_capsid(target_tissue):
    """Choose optimal AAV serotype for tissue."""
    if target_tissue == 'liver':
        return 'AAV8'  # 10-100x better liver transduction
    elif target_tissue == 'brain':
        return 'AAV9'  # Crosses BBB after systemic injection
    elif target_tissue == 'muscle':
        return 'AAV1'

Production & Titer

class AAVProduction:
    def produce_aav(self, vector_plasmid, helper_plasmids):
        """
        Triple transfection method:
        1. Vector plasmid (your gene)
        2. AAV rep/cap plasmid (packaging genes)
        3. Adenovirus helper plasmid
        """
        # Transfect HEK293 cells
        cells = HEK293T()
        cells.transfect([vector_plasmid, rep_cap, helper])

        # Harvest after 48-72 hours
        lysate = cells.lyse()

        # Purify AAV
        purified_aav = self.purify_by_iodixanol_gradient(lysate)

        # Titer (measure concentration)
        titer = self.measure_genome_copies(purified_aav)
        return purified_aav, titer

    def measure_genome_copies(self, aav_prep):
        """
        qPCR to quantify AAV genomes.
        Typical: 10^13 - 10^14 vg/mL (genome copies per mL)
        """
        return qpcr_quantification(aav_prep)

Risks ⚠️

def assess_aav_risks(vector):
    risks = []

    # 1. Integration (rare but possible)
    if vector.has_homology_to_genome():
        risks.append("Integration risk at AAVS1 locus")

    # 2. Immune response
    if patient.has_anti_aav_antibodies():
        risks.append("Pre-existing immunity may neutralize vector")

    # 3. Genotoxicity
    if vector.transgene_is_oncogene():
        risks.append("Insertional mutagenesis risk")

    # 4. Off-target transduction
    if not vector.is_tissue_specific():
        risks.append("Non-target tissue expression")

    return risks

Dosing: 10^12 - 10^14 vg/kg (patient weight-based)

Related Chronicles: Synthetic Blood Contamination (2032)

FDA Approved: Luxturna (retina), Zolgensma (SMA)

Share this article

Related Research